All Stories

  1. Associations of Hyponatremia with Cognition Function and All-Cause Mortality: Post-Hoc Analysis of the Systolic Blood Pressure Intervention Trial
  2. Targeting Sedentary Behavior in CKD
  3. The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes
  4. Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT
  5. A Randomized Controlled Trial of the Effects of Febuxostat Therapy on Adipokines and Markers of Kidney Fibrosis in Asymptomatic Hyperuricemic Patients With Diabetic Nephropathy
  6. Psoas Muscle Cross-sectional Area as a Measure of Whole-body Lean Muscle Mass in Maintenance Hemodialysis Patients
  7. Ambulatory Blood Pressure in Chronic Kidney Disease: Ready for Prime Time?
  8. The Associations of Plant Protein Intake With All-Cause Mortality in CKD
  9. Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults
  10. Food for Thought: Diet as a Risk Factor for CKD
  11. Dietary Management Software for Chronic Kidney Disease: Current Status and Open Issues
  12. Hypertension and Polypharmacy in Elderly Nursing Home Residents: When Less is More
  13. Sedentary Behavior in Individuals With Diabetic Chronic Kidney Disease and Maintenance Hemodialysis
  14. Supervised oral protein supplementation during dialysis in patients with elevated C-reactive protein levels: a two phase, longitudinal, single center, open labeled study
  15. Light-Intensity Physical Activities and Mortality in the United States General Population and CKD Subpopulation
  16. Nutrition and Chronic Kidney Disease
  17. Associations of Body Size and Body Composition with Functional Ability and Quality of Life in Hemodialysis Patients
  18. Improving CKD Therapies and Care: A National Dialogue
  19. Adiponectin retards the progression of diabetic nephropathy in db/db mice by counteracting angiotensin II
  20. Adiposity and Kidney Disease
  21. Changes in Anthropometry and Mortality in Maintenance Hemodialysis Patients in the HEMO Study
  22. Implications and Importance of Skeletal Muscle Mass in Estimating Glomerular Filtration Rate at Dialysis Initiation
  23. Risk Factor Paradox in CKD and ESRD: Does a Healthy Lifestyle Matter?
  24. Optimal Nutrition for Predialysis Chronic Kidney Disease
  25. Metabolic Syndrome, ESRD, and Death in CKD
  26. Serum bicarbonate and mortality in adults in NHANES III
  27. Effect of Donor Kidney Volume on Recipient Outcome
  28. Associations of Serum Skeletal Alkaline Phosphatase with Elevated C-Reactive Protein and Mortality
  29. Net endogenous acid production is associated with a faster decline in GFR in African Americans
  30. BODY COMPOSITION AND MORTALITY IN PREVALENT HEMODIALYSIS PATIENTS: HEMO STUDY
  31. SERUM CREATININE TO BODY WEIGHT RATIO-A SIMPLE MEAUSRE OF BODY COMPOSITION
  32. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease
  33. Cognitive Function and the Risk of Death in Chronic Kidney Disease
  34. Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III
  35. Associations of Serum Alkaline Phosphatase with Metabolic Syndrome and Mortality
  36. Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans
  37. Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease
  38. Serum alkaline phosphatase and mortality in hemodialysis patients
  39. 75: Assocations of Serum Alkaline Phosphatase With Elevated CRP in Chronic Kidney Disease Are Independent of Serum 25 OH Vitamin D Levels
  40. Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients
  41. Cardiovascular Disease: Coronary Artery Disease and Coronary Artery Calcification
  42. Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease
  43. Nutrition and Chronic Kidney Disease
  44. Outcome of End-Stage Renal Disease Therapies
  45. Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease
  46. The Influence of Age on Changes in Health-Related Quality of Life over Three Years in a Cohort Undergoing Hemodialysis
  47. Inflammation and Inverse Associations of Body Mass Index and Serum Creatinine With Mortality in Hemodialysis Patients
  48. CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: A Story Half Untold: Adiposity, Adipokines and Outcomes in Dialysis Population
  49. Lipoprotein Metabolism and Lipid Management in Chronic Kidney Disease
  50. Lack of Synergistic Effects of Metabolic Syndrome and Plasma Fibrinogen on Coronary Events and Mortality in Moderate CKD
  51. Hemodialysis Timing, Survival, and Cardiovascular Outcomes in the Hemodialysis (HEMO) Study
  52. Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis?
  53. If Fat is Good, Muscle is Better
  54. Cerebrovascular Disease in Maintenance Hemodialysis Patients: Results of the HEMO Study
  55. Normalization of Protein Intake by Body Weight and the Associations of Protein Intake With Nutritional Status and Survival
  56. Associations of Metabolic Syndrome With Inflammation in CKD: Results From the Third National Health and Nutrition Examination Survey (NHANES III)
  57. Patient preferences for in-center intense hemodialysis
  58. Nutrition and racial differences in cardiovascular events and survival in elderly dialysis patients
  59. Surgical revascularization versus amputation for peripheral vascular disease in dialysis patients: a cohort study
  60. Association of obesity with inflammation in chronic kidney disease: A cross-sectional study
  61. Association of obesity with inflammation in chronic kidney disease: A cross-sectional study
  62. Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study
  63. Hypothesis: The Body Mass Index Paradox and an Obesity, Inflammation, and Atherosclerosis Syndrome in Chronic Kidney Disease
  64. Malnutrition and Atherosclerosis in Dialysis Patients
  65. Impact of Timing of Initiation of Dialysis on Mortality
  66. Effects of Body Size and Body Composition on Survival in Hemodialysis Patients
  67. Say “no” and comorbidity
  68. Do associations with C-Reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency?
  69. Diagnosis and Therapy of Coronary Artery Disease in Renal Failure, End-Stage Renal Disease, and Renal Transplant Populations
  70. Creatinine Production, Nutrition, and Glomerular Filtration Rate Estimation
  71. Impact of renal failure on the risk of myocardial infarction and death
  72. Association of serum albumin and atherosclerosis in chronic hemodialysis patients
  73. The Clinical and Morphologic Spectrum of Renal Cryoglobulinemia
  74. The effects of comorbid conditions on the outcomes of patients undergoing peritoneal dialysis
  75. Models of capitated payment for endstage renal disease: the reply
  76. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients
  77. Adiposity and Kidney Disease